“Good” Heroin, “Bad” Methadone: Moral Governance and the Politics of Treatment in Kyrgyz Prisons

Why does heroin circulate as a “good” drug in Kyrgyz prisons, while methadone is deemed morally degrading? Drawing on ethnographic fieldwork (2015–2019) in three Kyrgyz correctional facilities, this article examines how drugs come to organize moral life in prison. We argue that methadone's limited uptake is not best explained as an “implementation barrier.” Instead, heroin and methadone enact competing moral orders that sort belonging and loyalty inside prison walls. Heroin circulates through the prisoner-governed collective, producing relational dependency and reinforcing informal authority. Methadone is dispensed under state supervision, producing bureaucratic visibility and aligning users with institutional compliance, functioning less as treatment than as a mode of governance. In this setting, to accept methadone is to risk moral downgrading within the prisoner collective; to refuse it is to defend a moral economy in which heroin paradoxically becomes the substance of belonging. By foregrounding drugs as boundary-making devices, we challenge the effective/ineffective binary in addiction treatment scholarship and show how pharmacological interventions are negotiated across competing ethical regimes.

Authors

Institutions

Publication Details

Journal
Contemporary Drug Problems
Published
2026-09-24
DOI
https://doi.org/10.1177/00914509261489638
Primary Topic
HIV, Drug Use, Sexual Risk
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

“Good” Heroin, “Bad” Methadone: Moral Governance and the Politics of Treatment in Kyrgyz Prisons

Lyu Azbel, Mary M. Tate
Contemporary Drug Problems
HIV, Drug Use, Sexual Risk
article

“Good” Heroin, “Bad” Methadone: Moral Governance and the Politics of Treatment in Kyrgyz Prisons

Lyu Azbel, Mary M. Tate
article en

Abstract

Why does heroin circulate as a “good” drug in Kyrgyz prisons, while methadone is deemed morally degrading? Drawing on ethnographic fieldwork (2015–2019) in three Kyrgyz correctional facilities, this article examines how drugs come to organize moral life in prison. We argue that methadone's limited uptake is not best explained as an “implementation barrier.” Instead, heroin and methadone enact competing moral orders that sort belonging and loyalty inside prison walls. Heroin circulates through the prisoner-governed collective, producing relational dependency and reinforcing informal authority. Methadone is dispensed under state supervision, producing bureaucratic visibility and aligning users with institutional compliance, functioning less as treatment than as a mode of governance. In this setting, to accept methadone is to risk moral downgrading within the prisoner collective; to refuse it is to defend a moral economy in which heroin paradoxically becomes the substance of belonging. By foregrounding drugs as boundary-making devices, we challenge the effective/ineffective binary in addiction treatment scholarship and show how pharmacological interventions are negotiated across competing ethical regimes.

Contemporary Drug Problems
University of Cambridge (GB), Yale University (US)
Good health and well-being
Openalex Percentile: Top 11%
HIV, Drug Use, Sexual Risk
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

“Good” Heroin, “Bad” Methadone: Moral Governance and the Politics of Treatment in Kyrgyz Prisons — Lyu Azbel, Mary M. Tate · Contemporary Drug Problems (2026) | TGRS Research Map | TGRS